Pharmaceutical & biomedical research likely to use $1 billion worth of microfluidics devices by 2016
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Analysis, Assay development optimisation & technology, Automation / robotics, Biomarkers, Business, Cellular & Molecular biology, Cellular assays, Chemical engineering, Chemistry, Drug development, Drug discovery, Enabling technologies, Genomics, High Content Screening, High throughput screening, Imaging, Microfluidics, Organic chemistry, PCR, Protein chemistry / Proteomics, RNA, Screening, Sequencing, Stem cells, Toxicology
